scorecardresearch
Wednesday, September 3, 2025
TopicDiabetes

Topic: Diabetes

After ‘sugar boards’, CBSE asks schools to display ‘oil boards’ to promote healthy eating among students

CBSE said schools can take creative liberty in localising ‘boards’ while adhering to core message of promoting a healthier school environment.

ICMR-NIE launches initiative to tackle poor follow-ups, gaps in diabetes, hypertension treatment

Fewer than 10 percent of people with hypertension had their blood sugar under control & fewer than 66 percent of diabetics had metabolic disorder under control in 2019-21.

Eli Lilly announces trial results for world’s 2nd weekly insulin, aims for launch by year-end

New Delhi: There is excitement and hope in the insulin market the world over after U.S. based pharma giant Eli Lilly & Company on...

Over 40% hospitals below district level lack basic diabetes, hypertension drugs—ICMR-WHO survey of 7 states

Survey also found a shortage of 82.2% physicians and 83.2% surgeons at community health centre-level facilities, considered crucial for providing secondary-level healthcare services. 

Big pharma pivoting to more lucrative obesity segment, Indian drugmakers eye insulin market

The size of India’s insulin market was an estimated Rs 4,404 crore in April this year, with Indian players making steady entry into a market once dominated by Big pharma.

CBSE asks schools to establish ‘sugar boards’ to monitor & reduce sugar consumption among children

The move comes after the board’s decision to allow students with Type 1 diabetes to carry insulin pumps and glucometers into examination halls.

New subtype of diabetes found in India could change how rare forms of disease are treated

The landmark achievement in diabetes research in the country could potentially transform how certain rare forms of the disease are diagnosed & treated worldwide.

Silent threat of diabetic retinopathy: Eye doctors bat for advanced treatments to be part of AB-PMJAY

Diabetic retinopathy affects 30 lakh Indians and can lead to vision loss. Advanced therapies include costly injections currently not covered under Centre’s healthcare scheme.  

Fat-busting drug Mounjaro launched in India. Here’s how much it will cost

US pharma giant Eli Lilly's Mounjaro can prove crucial in treatment of obesity & type 2 diabetes. Launched in the US in 2022, it has since become a global blockbuster.

Swapping ghar ka khaana with ready-to-eat foods? 66% beverages have high sugar, 97% snacks high fat

Govt-funded study analysed front and back of labels of 432 popular packaged food products including breakfast cereals, idli mixes, porridges, soup mixes, beverages and extruded snacks.

On Camera

Chinese memes, videos & commentaries say Modi overshadowed other leaders at SCO

On Douyin, many videos highlighted how Modi was all smiles during his China visit. Others focused on his handholding with Putin and Trump’s supposed irritation.

A Rs 33,000 cr ‘banking fraud’: ED’s case against Arvind Dham, Amtek’s web of ‘500 shell companies’

ED has accused Amtek promoter Arvind Dham of controlling web of nearly 500 shell companies operating as a layered structure, with up to 15 levels of indirect ownership, to divert funds.

‘Real-time, all-climate’ explosives detector could enhance airport & border security—no dogs, no swabs

Bengaluru-based CeNS designs accurate, portable, and cheap sensor using surface-enhanced Raman spectroscopy. It could significantly reduce risks at vulnerable choke points. 

For Indian Mercedes, Asim Munir’s dumper truck in mirror is closer than it appears

From Munir’s point of view, a few bumps here and there is par for the course. He isn’t going to drive his dumper truck to its doom. He wants to use it as a weapon.